Searched for
CDMO BUSINESS
Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoY- Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
- Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?
- PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horsesHDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 20...08 Nov, 2026, 01.09 PM IST
- More than family business: Drugmakers make costly, long-term strategic shifts as next generation steps into bigger rolesIndia's family-run pharmaceutical companies are entering a new phase as the next generation takes on larger leadership roles and steers bus...07 Nov, 2026, 11.44 PM IST
- Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...07 Nov, 2026, 05.39 PM IST
- Alivus Life Sciences block deal: Promoter Nirma sells over 28 lakh shares worth Rs 390 crore; Norges Bank, Helios MF among buyersNirma sold 28.46 lakh Alivus Life Sciences shares worth Rs 390 crore through a block deal at Rs 1,370 apiece. Norges Bank, Bandhan MF and o...06 Nov, 2026, 08.59 PM IST
- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...05 Nov, 2026, 11.49 AM IST
- These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...05 Nov, 2026, 11.49 AM IST
- Beyond tech: Kotak MF’s Shibani Kurian on India’s next innovation-led winnersInnovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...03 Nov, 2026, 10.30 AM IST
- Diwali investment picks 2026: 10 fund managers reveal promising opportunities and risks to watchThis Diwali, investment experts advise a strategic approach focused on asset allocation rather than luring high-growth stocks. Sectors like...02 Nov, 2026, 03.43 PM IST
- How Indian investors’ portfolios are changing: From property and gold to SIPs and ETFsIndian households are re-evaluating their asset allocations as gold holdings rise and equity investments remain stable. Recent data reveals...02 Nov, 2026, 11.07 AM IST
- Diwali 2026: 77 stocks knock down D-St bears to deliver multibagger returns of up to 4,700% in a yearWith Diwali 2026 on the horizon, 77 stocks have thrived despite market fluctuations, marking exceptional returns. Mrugesh Trading showcases...02 Nov, 2026, 09.53 AM IST
- Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...30 Oct, 2026, 10.31 AM IST
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhen a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...28 Oct, 2026, 11.11 PM IST
- Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini PiramalIn a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The ...28 Oct, 2026, 06.10 PM IST
- Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginallyDr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America ...23 Oct, 2026, 07.02 PM IST
- From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plansBiodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture ...23 Oct, 2026, 01.04 PM IST
- From CDMO to aerospace: How Vikas Khemani finds India’s next big themesNow, as Carnelian has ventured into mutual fund business by launching a small-cap fund with a ₹5,000 crore cap, Khemani is focusing on manu...23 Oct, 2026, 09.00 AM IST
- Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upsideNuvama Institutional Equities has initiated coverage on Laurus Labs with a ‘Buy’ rating and a target price of Rs 2,520, implying a 24% upsi...16 Oct, 2026, 03.22 PM IST
Load More
